|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1998-11-3
|
|
pubmed:abstractText |
Prostate-specific membrane antigen (PSMA) is an integral membrane protein highly specific for the prostate. PSMA may be clinically useful for predicting outcome in patients with prostate cancer. We compared the expression of PSMA in prostate adenocarcinoma and lymph node metastases in a large series of patients with node-positive cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0090-4295
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
52
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
637-40
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9763084-Adenocarcinoma,
pubmed-meshheading:9763084-Antigens, Neoplasm,
pubmed-meshheading:9763084-Antigens, Surface,
pubmed-meshheading:9763084-Carboxypeptidases,
pubmed-meshheading:9763084-Glutamate Carboxypeptidase II,
pubmed-meshheading:9763084-Humans,
pubmed-meshheading:9763084-Lymphatic Metastasis,
pubmed-meshheading:9763084-Male,
pubmed-meshheading:9763084-Prostatic Neoplasms
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases.
|
|
pubmed:affiliation |
Department of Laboratory Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review
|
